265 related articles for article (PubMed ID: 17309497)
1. Comparison of the effects of acylation and amidation on the antimicrobial and antiviral properties of lactoferrin.
Pan Y; Wan J; Roginski H; Lee A; Shiell B; Michalski WP; Coventry MJ
Lett Appl Microbiol; 2007 Mar; 44(3):229-34. PubMed ID: 17309497
[TBL] [Abstract][Full Text] [Related]
2. Charge modification of plasma and milk proteins results in antiviral active compounds.
Swart PJ; Harmsen MC; Kuipers ME; Van Dijk AA; Van Der Strate BW; Van Berkel PH; Nuijens JH; Smit C; Witvrouw M; De Clercq E; de Béthune MP; Pauwels R; Meijer DK
J Pept Sci; 1999 Dec; 5(12):563-76. PubMed ID: 10628656
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial mechanisms and potential clinical application of lactoferrin].
Rodríguez-Franco DA; Vázquez-Moreno L; Ramos-Clamont Montfort G
Rev Latinoam Microbiol; 2005; 47(3-4):102-11. PubMed ID: 17061535
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin.
van der Kraan MI; Groenink J; Nazmi K; Veerman EC; Bolscher JG; Nieuw Amerongen AV
Peptides; 2004 Feb; 25(2):177-83. PubMed ID: 15062998
[TBL] [Abstract][Full Text] [Related]
5. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial properties of lactoferrin.
Jenssen H; Hancock RE
Biochimie; 2009 Jan; 91(1):19-29. PubMed ID: 18573312
[TBL] [Abstract][Full Text] [Related]
7. Short communication: Antimicrobial effect of lactoferrin and its amidated and pepsin-digested derivatives against Salmonella Enteritidis and Pseudomonas fluorescens.
Del Olmo A; Calzada J; Nuñez M
J Dairy Sci; 2010 Sep; 93(9):3965-9. PubMed ID: 20723671
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin: structure, function and applications.
González-Chávez SA; Arévalo-Gallegos S; Rascón-Cruz Q
Int J Antimicrob Agents; 2009 Apr; 33(4):301.e1-8. PubMed ID: 18842395
[TBL] [Abstract][Full Text] [Related]
9. Identification of milk proteins enhancing the antimicrobial activity of lactoferrin and lactoferricin.
Murata M; Wakabayashi H; Yamauchi K; Abe F
J Dairy Sci; 2013 Aug; 96(8):4891-8. PubMed ID: 23769363
[TBL] [Abstract][Full Text] [Related]
10. Influence of desiccation on the sensitivity of Cronobacter spp. to lactoferrin or nisin in broth and powdered infant formula.
Al-Nabulsi AA; Osaili TM; Al-Holy MA; Shaker RR; Ayyash MM; Olaimat AN; Holley RA
Int J Food Microbiol; 2009 Dec; 136(2):221-6. PubMed ID: 19720412
[TBL] [Abstract][Full Text] [Related]
11. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.
Andersen JH; Jenssen H; Sandvik K; Gutteberg TJ
J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin inhibits human papillomavirus binding and uptake in vitro.
Drobni P; Näslund J; Evander M
Antiviral Res; 2004 Oct; 64(1):63-8. PubMed ID: 15451180
[TBL] [Abstract][Full Text] [Related]
13. Twenty-five years of research on bovine lactoferrin applications.
Tomita M; Wakabayashi H; Shin K; Yamauchi K; Yaeshima T; Iwatsuki K
Biochimie; 2009 Jan; 91(1):52-7. PubMed ID: 18585434
[TBL] [Abstract][Full Text] [Related]
14. Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.
Zarzosa-Moreno D; Avalos-Gómez C; Ramírez-Texcalco LS; Torres-López E; Ramírez-Mondragón R; Hernández-Ramírez JO; Serrano-Luna J; de la Garza M
Molecules; 2020 Dec; 25(24):. PubMed ID: 33302377
[TBL] [Abstract][Full Text] [Related]
15. Potential lactoferrin activity against pathogenic viruses.
Redwan EM; Uversky VN; El-Fakharany EM; Al-Mehdar H
C R Biol; 2014 Oct; 337(10):581-95. PubMed ID: 25282173
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activities of lactoferrin.
van der Strate BW; Beljaars L; Molema G; Harmsen MC; Meijer DK
Antiviral Res; 2001 Dec; 52(3):225-39. PubMed ID: 11675140
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo (LD50) effects of human lactoferrin on bacteria.
Czirók E; Milch H; Németh K; Gadó I
Acta Microbiol Hung; 1990; 37(1):55-71. PubMed ID: 2124771
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of lactoferrin on in vitro growth of Babesia caballi.
Ikadai H; Tanaka T; Shibahara N; Tanaka H; Matsuu A; Kudo N; Shimazaki K; Igarashi I; Oyamada T
Am J Trop Med Hyg; 2005 Oct; 73(4):710-2. PubMed ID: 16222014
[TBL] [Abstract][Full Text] [Related]
20. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity.
Di Biase AM; Pietrantoni A; Tinari A; Siciliano R; Valenti P; Antonini G; Seganti L; Superti F
J Med Virol; 2003 Apr; 69(4):495-502. PubMed ID: 12601757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
